Inspire Investing, LLC Incyte Corp Transaction History

Inspire Investing, LLC

$959 Million
Q3 2024

A detailed history of Inspire Investing, LLC transactions in Incyte Corp stock. As of the latest transaction made, Inspire Investing, LLC holds 21,574 shares of INCY stock, worth $1.55 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares

21,574

Previous 25,113 14.09%

Holding current value

$1.55 Million

Previous $1.52 Million 6.31%

% of portfolio

0.15%

Previous 0.18%

34 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 10, 2024	SELL	$57.33 - $68.61 $202,890 - $242,810	-3,539 Reduced 14.09%	21,574 $1.43 Million
Q2 2024 Aug 12, 2024	SELL	$51.18 - $63.75 $408,979 - $509,426	-7,991 Reduced 24.14%	25,113 $1.52 Million
Q1 2024 May 07, 2024	BUY	$56.55 - $66.59 $276,077 - $325,092	4,882 Added 17.3%	33,104 $1.89 Million
Q4 2023 Feb 12, 2024	BUY	$52.16 - $64.19 $63,948 - $78,696	1,226 Added 4.54%	28,222 $1.77 Million
Q3 2023 Oct 26, 2023	SELL	$57.77 - $65.93 $226,631 - $258,643	-3,923 Reduced 12.69%	26,996 $1.56 Million
Q2 2023 Jul 31, 2023	SELL	$60.95 - $75.51 $119,827 - $148,452	-1,966 Reduced 5.98%	30,919 $1.92 Million
Q1 2023 Apr 24, 2023	SELL	$70.23 - $86.01 $655,597 - $802,903	-9,335 Reduced 22.11%	32,885 $2.38 Million
Q4 2022 Jan 26, 2023	SELL	$67.18 - $84.11 $6,180 - $7,738	-92 Reduced 0.22%	42,220 $0
Q3 2022 Nov 07, 2022	BUY	$66.18 - $82.86 $56,782 - $71,093	858 Added 2.07%	42,312 $2.82 Million
Q2 2022 Aug 10, 2022	SELL	$66.18 - $83.18 $191,855 - $241,138	-2,899 Reduced 6.54%	41,454 $3.15 Million
Q1 2022 Apr 21, 2022	SELL	$66.02 - $79.71 $173,500 - $209,477	-2,628 Reduced 5.59%	44,353 $3.52 Million
Q4 2021 Feb 14, 2022	BUY	$63.34 - $74.11 $2.98 Million - $3.48 Million	46,981 New	46,981 $3.45 Million
Q4 2021 Feb 03, 2022	SELL	$63.34 - $74.11 $2.54 Million - $2.97 Million	-40,126 Closed	0 $0
Q3 2021 Nov 09, 2021	BUY	$68.67 - $84.02 $1.88 Million - $2.31 Million	27,434 Added 216.15%	40,126 $2.76 Million
Q2 2021 Aug 10, 2021	BUY	$79.87 - $87.53 $201,591 - $220,925	2,524 Added 24.82%	12,692 $1.07 Million
Q1 2021 Apr 30, 2021	BUY	$76.02 - $100.5 $339,429 - $448,732	4,465 Added 78.29%	10,168 $826,000
Q4 2020 Feb 12, 2021	BUY	$80.74 - $97.7 $118,203 - $143,032	1,464 Added 34.54%	5,703 $496,000
Q3 2020 Nov 16, 2020	BUY	$85.07 - $109.69 $70,182 - $90,494	825 Added 24.17%	4,239 $380,000
Q2 2020 Aug 12, 2020	SELL	$74.18 - $108.93 $111,047 - $163,068	-1,497 Reduced 30.48%	3,414 $355,000
Q1 2020 May 08, 2020	SELL	$63.18 - $85.97 $93,253 - $126,891	-1,476 Reduced 23.11%	4,911 $360,000
Q4 2019 Jan 24, 2020	BUY	$73.04 - $95.72 $25,564 - $33,502	350 Added 5.8%	6,387 $558,000
Q3 2019 Nov 13, 2019	BUY	$72.82 - $86.52 $19,879 - $23,619	273 Added 4.74%	6,037 $448,000
Q2 2019 Jul 16, 2019	BUY	$73.52 - $88.7 $31,098 - $37,520	423 Added 7.92%	5,764 $490,000
Q1 2019 May 16, 2019	BUY	$63.56 - $88.17 $66,610 - $92,402	1,048 Added 24.41%	5,341 $459,000
Q4 2018 Feb 22, 2019	BUY	$58.5 - $69.94 $251,140 - $300,252	4,293 New	4,293 $273,000
Q4 2018 Feb 01, 2019	SELL	$58.5 - $69.94 $267,988 - $320,395	-4,581 Closed	0 $0
Q3 2018 Feb 22, 2019	BUY	$61.75 - $74.23 $7,224 - $8,684	117 Added 2.62%	4,581 $316,000
Q3 2018 Nov 07, 2018	BUY	$61.75 - $74.23 $34,209 - $41,123	554 Added 14.17%	4,464 $308,000
Q2 2018 Feb 22, 2019	BUY	$60.85 - $83.98 $237,923 - $328,361	3,910 New	3,910 $262,000
Q2 2018 Jul 19, 2018	SELL	$60.85 - $83.98 $177,742 - $245,305	-2,921 Closed	0 $0
Q1 2018 Feb 22, 2019	BUY	$83.06 - $100.98 $242,618 - $294,962	2,921 New	2,921 $243,000
Q1 2018 Apr 13, 2018	SELL	$83.06 - $100.98 $154,159 - $187,418	-1,856 Closed	0 $0
Q4 2017 Feb 22, 2019	BUY	$93.56 - $116.6 $172,056 - $214,427	1,839 Added 10817.65%	1,856 $176,000
Q4 2017 Feb 15, 2018	BUY	$93.56 - $116.6 $1,590 - $1,982	17	17 $2,000

Others Institutions Holding INCY

# of Institutions

643

Shares Held

186M

Call Options Held

714K

Put Options Held

557K

View Full List

About INCYTE CORP

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $16B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

More about INCY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Inspire Investing, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Inspire Investing, LLC with notifications on news.

Account

Inspire Investing, LLC Incyte Corp Transaction History